new weight loss drug retatrutide shows significant in obesity and knee osteoarthritis trial | Ahmad Bahareth, MD posted on the topic Retatrutide 2026: 28.7% Weight Loss
Description
You may not be able to control every menstrual fluctuation, but you can support your body through the transition period

Additionally, the medication should be used with a reduced-calorie diet and increased physical activity

Suppression of food intake by GLP-1R agonism has been demonstrated in numerous species including mice [[465], [466], [467],665,666], rats [667,668], birds [669,670], pigs [671,672], non-human primates [673,674], and humans [[675], [676], [677], [678]]

Yet weight regain after stopping anti-obesity pharmacotherapy is still too often interpreted as therapeutic failure

If youve suffered after taking Ozempic, the best time to act is now
